Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.13.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.13.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.13.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.13.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GV.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GV.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GV.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GV.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DY.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DY.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DY.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DY.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DY.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HH.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HH.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HH.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HH.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HH.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EM.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EM.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EM.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EM.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EM.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FD.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FD.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FD.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used